Treatment
Treatment clinical trials
We’re tracking 8,312 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07838415Recruiting
Mapping the immune landscape in liver cancer
This study uses advanced MRI scans and tumor samples to understand how the immune system behaves in liver cancer. It aims to improve personalized treatment by looking at the tumor's environment at different times.
Wuhan, HubeiAges 18–80 - NCT07834606Recruiting
Virtual reality tool for teens with alcohol or cannabis use
This trial tests if a virtual reality program, alongside usual care, helps young people in residential treatment reduce alcohol and cannabis use. It's designed for teens and young adults aged 13-21 who are staying in a residential program for at least six months.
Pozuelo de Alarcón, MadridAges 13–21 - NCT04463498Recruiting
Sleep school program for insomnia alongside mental health problems
This trial tests a group “sleep school” program to improve sleep when insomnia happens together with moderate to severe mental health symptoms. It may help you learn practical sleep strategies and improve sleep quality while you’re getting psychiatric care.
BergenAges 18–80 - NCT05346068Recruiting
Compare two balloon types for calcium-heavy blocked heart arteries
This trial studies whether one type of balloon works better than another for treating badly calcified (hardened) coronary artery blockages. If you qualify, you would be randomly assigned to get the tested balloon treatment during your heart procedure.
LucerneAges 18 years+ - NCT06451510Recruiting
Knee osteoarthritis study in Northern Sweden
This trial studies knee osteoarthritis in people from Norrbotten, Sweden, who broke their tibial plateau between 2001 and 2015. It aims to understand how the injury affects the knee over time.
Luleå, Norrbotten CountyAges 18 years+ - NCT06464744Recruiting
Can brain stimulation help after spinal cord injury?
This trial tests whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive treatment that uses magnetic pulses to stimulate the brain, can improve movement and function in people with chronic spinal cord injury. It may help if you have some movement left below your injury level.
OsloAges 18–80 - NCT06464757Recruiting
Laryngomalacia and breathing in children: before and after treatment study
This trial is for children with laryngomalacia (a floppy voice box) who have noisy breathing and trouble breathing. It will check how they are doing before and after treatment, and follow up for one year to see how their quality of life improves.
OsloAges 1 week–12 months - NCT06464068RecruitingPhase 2
Immunotherapy plus chemo for first-line advanced extrapulmonary small cell cancer
This trial tests a new combination of durvalumab (an immunotherapy) plus standard chemotherapy for people with advanced small cell carcinoma that started outside the lung and has not been treated before. The goal is to see if this combo works better than chemo alone.
Reggio EmiliaAges 18 years+ - NCT06463834RecruitingPhase 2
Sintilimab plus chemo before surgery for esophageal cancer
This study tests a combination of an immunotherapy drug (sintilimab) with chemotherapy given before surgery for a type of esophageal cancer called squamous cell carcinoma. The goal is to see if this treatment shrinks the tumor and improves outcomes.
Fuzhou, FujianAges 18–75 - NCT05469945Recruiting
Prevention study for leg swelling after gynecologic cancer treatment
This study looks at what to do to help prevent or better manage leg swelling (lymphedema) after treatment for certain gynecologic cancers. You may be asked to use a diary or app and complete questionnaires so the team can track symptoms over time.
GhentAges 18–99 - NCT07829302RecruitingPhase 1/Phase 2
Gene therapy for type 1 diabetes
This trial tests an investigational gene therapy that may help people with type 1 diabetes produce some insulin on their own, potentially reducing the amount of insulin they need. It is an early-stage study, so participants will be closely monitored for safety and any changes in their diabetes control.
MelbourneAges 18–65 - NCT07831798RecruitingPhase 1/Phase 2
Gene therapy for type 1 diabetes
This study tests a new gene therapy (VV-14300) that aims to help people with type 1 diabetes make insulin again. It might improve blood sugar control and reduce the need for insulin.
TorontoAges 18–65 - NCT07828184Recruiting
Filmogel topical treatment for toenail fungus
This trial tests a gel applied to the toenail that may treat mild to moderate fungus infections in one or two big toenails. It aims to see if the film-forming gel helps clear the infection.
DijonAges 18–85 - NCT07829614RecruitingPhase 1
F182112 study for people with lupus
This study tests a new drug called F182112 for people with systemic lupus erythematosus (SLE), a condition where the immune system attacks the body. The drug targets certain immune cells to possibly reduce lupus symptoms.
ShanghaiAges 18–65 - NCT06470646Recruiting
Endovascular treatment for dialysis graft problems
This trial studies a procedure to open up blocked or narrowed areas in the plastic tube (graft) used for dialysis. It aims to see if the procedure works well and if it is cost-effective for patients who have trouble completing dialysis because of graft issues.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07830602Recruiting
Home breathing and exercise program for interstitial lung disease
This study tests a home-based program of breathing exercises and physical activity for people with interstitial lung disease, aiming to improve breathlessness and daily function.
Chandigarh, ChandigarhAges 18–75 - NCT07829887Recruiting
Measuring brain oxygen after cardiac arrest
This study tests a device that measures oxygen levels in the brain during recovery from cardiac arrest. It aims to see if monitoring brain oxygen helps doctors make better treatment decisions after the heart restarts.
Calgary, AlbertaAges Any age - NCT07828015RecruitingPhase 2
Bevacizumab for hereditary hemorrhagic telangiectasia
This trial tests whether bevacizumab, a drug that blocks blood vessel growth, can reduce bleeding in people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and frequent nosebleeds.
Hangzhou, ZhejiangAges 18–75 - NCT07833696Recruiting
Study of severe hives that don't respond to omalizumab
This study looks at people with severe hives (chronic urticaria) that have not improved with the usual dose of the medicine omalizumab. It aims to better understand these cases and how they are managed, which may help improve future care.
Besançon, Franche-comtéAges 18–80 - NCT07831993RecruitingPhase 2
Immunotherapy with chemotherapy for advanced bile duct cancer
This trial tests a new combination of a drug that helps your immune system fight cancer, called sintilimab, along with chemotherapy. It is for people who have bile duct cancer or gallbladder cancer that has spread to other parts of the body and have not had treatment for this stage yet. The goal is to see if this combination helps shrink tumors or stops them from growing.
Nanjing, JiangsuAges 18–75 - NCT07832188Recruiting
Brain stimulation for chronic lower back pain
This study tests a non-invasive brain stimulation technique that uses gentle electrical currents to target the part of the brain involved in pain processing. It may help reduce chronic lower back pain that is not caused by a specific injury or condition.
Jinan, ShandongAges 18–80 - NCT07831902RecruitingPhase 3
Hormone tablets plus radiotherapy for certain endometrial cancers
This trial compares two ways to treat endometrial cancer after surgery: a new option of just radiotherapy plus a daily hormone tablet (progestin) versus the current standard of radiotherapy plus chemotherapy. It aims to see if the new option works just as well with fewer side effects.
BathAges 18 years+ - NCT07827833Recruiting
Dental fillings and crowns for children under general anesthesia
This study looks at how well dental fillings and crowns hold up in children who get all their dental work done in one visit while asleep with general anesthesia. It aims to see which restorations work best over 24 months.
TantaAges 3–6 - NCT06478927Recruiting
Palbociclib for advanced liver cancer after other treatments
This trial tests a drug called palbociclib for people with advanced liver cancer who have already tried at least two other treatments. The goal is to see if palbociclib can help shrink the cancer or slow its growth.
Zhengzhou, HenanAges 18–75
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.